Get the Stockscreener App
180.13
2.10%
-3.564
Davita Inc stock is traded at $180.13, with a volume of 427.06K.
It is down -2.10% in the last 24 hours and down -22.75% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$183.69
Open:
$183.18
24h Volume:
427.06K
Relative Volume:
0.51
Market Cap:
$11.56B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
17.29
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
-21.12%
1M Performance:
-22.75%
6M Performance:
+24.65%
1Y Performance:
+39.35%
1-Day Range:
$179.16
$186.96
1-Week Range:
$176.59
$208.53
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
180.12 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
411.80 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
261.73 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.91 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
126.25 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita Healthcare Partners stock hits all-time high at 239.72 USD - Investing.com Canada
DaVita Inc (DVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DaVita Inc (DVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DaVita Inc (DVA) Income Statement - TradingKey
DaVita Inc (DVA) Institutional Confidence - TradingKey
DVA|DaVita Inc|Price:236.300|Chg%:+0.860 - TradingKey
DaVita stock trades steadily as dialysis volumes support margins - Ad-hoc-news.de
DVA|DaVita Inc|Price:235.440|Chg%:+1.160 - TradingKey
DaVita Inc. Revenue Breakdown – NYSE:DVA - TradingView
DaVita stock holds steady after recent earnings context - AD HOC NEWS
Davita: Valuation Is Nearing Resistance Level (NYSE:DVA) - Seeking Alpha
DaVita stock trades steadily as recent quarterly earnings highlight stable dialysis demand - AD HOC NEWS
DaVita Company Profile & Introduction - Moomoo
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Moon Capital Management Exited DaVita (DVA) with 174% total Return - Yahoo Finance
DaVita stock trades steadily as dialysis volumes support revenue growth - Ad-hoc-news.de
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Summer Heat, Hydration and ESKD: Mitigating Health Risks - DaVita Newsroom
DaVita stock holds on dialysis revenue and margin trends - AD HOC NEWS
DaVita Inc. to announce Q2FY26 results on August 4 - scanx.trade
DaVita schedules Q2 earnings call for August 4, 2026, after market close. - Pluang
DaVita Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call - KITV
What you need to know ahead of DaVita’s earnings release - MSN
DaVita stock trades steady as dialysis operator highlights cash flow and growth investments - AD HOC NEWS
DaVita stock holds firm as earnings and cash flow support dialysis strategy - Ad-hoc-news.de
DaVita stock benefits from expanding community-based kidney care - MSN
DaVita stock trades steadily as dialysis margins and leverage stay in focus - Ad-hoc-news.de
DaVita stock trades steady as chronic kidney care demand supports earnings trajectory - Ad-hoc-news.de
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Wins Bid To Decertify 1,300-Member Collective - Law360
DaVita: Why We Exited Our Position In Q2 (DVA) - Seeking Alpha
DaVita gains 21.4% in three months: How should you play the stock? - MSN
DaVita stock trades steadily as kidney care margins and cash flow support valuation - Ad-hoc-news.de
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
DaVita shares more than double after strong Q1 and court win; analyst sells most shares, rates Hold. - Pluang
DaVita: I Believe This Is Overvalued (NYSE:DVA) - Seeking Alpha
What You Need To Know Ahead of DaVita’s Earnings Release - Yahoo Finance
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Truist Raises Price Target on DaVita to $250 From $205, Keeps Hold Rating - Moomoo
Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $250 - Moomoo
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita stock holds steady as kidney care specialist focuses on operations and long-term dialysis dem - ad-hoc-news.de
DaVita Inc. (DVA) Stock Analysis: Strong ROE And Growth Potential In Healthcare Sector - DirectorsTalk Interviews
Exciting News for Farmington: DaVita Maple Valley is Expandi... - Park Hills Daily Journal
DaVita stock reflects steady dialysis demand amid US healthcare focus - ad-hoc-news.de
DVA stock holds steady as dialysis demand underpins the long-term case - ad-hoc-news.de
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Yahoo Finance
DaVita Can Return to Long-Term Volume Growth of 2% by 2029, UBS Says - Moomoo
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
1.94%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):